Nucleic Acid Sample Preparation Market Size is valued at USD 2.89 Billion in 2023 and is predicted to reach USD 4.57 Billion by the year 2031 at a 6.10% CAGR during the forecast period for 2024-2031. Molecular biology relies on nucleic acid sample preparation to extract, purify, and concentrate DNA or RNA from blood, tissue, cell, and environmental samples. High-quality nucleic acids are essential for genetic and molecular analysis like PCR, N...
Report ID: 2386 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
The Swab And Viral Transport Medium Market Size is valued at 8.09 Billion in 2023 and is predicted to reach 13.16 Billion by the year 2031 at a 6.47 % CAGR during the forecast period for 2024-2031. Viral transport medium is used to collect, transport, maintain and store the clinical specimens containing viruses, chlamydia, mycoplasma or ureaplasma organisms. A viral skin swab is lightly rubbed against a visible skin lesion or vesicle and ...
Report ID: 1125 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
The Global Plant-Based API Market Size is predicted to witness a 7.49% CAGR during the forecast period for 2023-2031. Active Pharmaceutical Ingredients (APIs) and excipients are the two most essential components in the manufacture of medication. The API is the chemical from which the medication is created. In contrast, the excipient is a component that isn't the drug but works as a medium that allows the body to absorb the medicine, including la...
Report ID: 1715 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Combo IVD Market Size is valued at USD 550.12 Mn in 2023 and is predicted to reach USD 920.86 Mn by the year 2031 at a 6.84% CAGR during the forecast period for 2024-2031. Combo in vitro diagnostics (IVDs) refers to medical tools that measure and analyze biological samples in a controlled environment. These tests are useful for detecting and monitoring a wide range of medical illnesses, including infectious disorders and autoimmune diseases. T...
Report ID: 2376 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Coagulation Factor Deficiency Market Size is valued at USD 5.50 Bn in 2023 and is predicted to reach USD 9.60 Bn by the year 2031 at a 7.36% CAGR during the forecast period for 2024-2031. Coagulation factor deficiency refers to a medical disorder characterized by an inadequate or malfunctioning of coagulation factors, which are proteins responsible for blood clotting. This can result in hemorrhagic diseases, manifesting as signs suc...
Report ID: 2163 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
Chapel Disease Therapeutics Market Size is valued at USD 144.89 Mn in 2023 and is predicted to reach USD 161.10 Mn by the year 2031 at a 1.41% CAGR during the forecast period for 2024-2031. Chapel Syndrome is a rare genetic condition affecting the immune system. CHAPLE stands for "CD55 deficiency, hyperactivation, angiopathic thrombosis, and severe protein-losing enteropathy (PLE)." Chaple is characterized by severe protein-losing enteropathy,...
Report ID: 2360 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Omics-Based Clinical Trials Market Size is valued at USD 29.51 billion in 2023 and is predicted to reach USD 54.42 billion by the year 2031 at a 8.13% CAGR during the forecast period for 2023-2031. Omics-based clinical trials represent a significant shift towards more precise and personalized healthcare, offering the promise of better-targeted therapies with higher efficacy and fewer side effects. As the field evolves, continued advancements i...
Report ID: 2355 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Autoimmune Polyglandular Syndrome Type 1 Market Size is valued at USD 244.1 Mn in 2023 and is predicted to reach USD 389.6 Mn by the year 2031 at a 6.20% CAGR during the forecast period for 2024-2031. Autoimmune Polyglandular Syndrome type 1 is an uncommon autosomal recessive disorder characterized by hypoparathyroidism, adrenal insufficiency, and chronic mucocutaneous candidiasis. These are its three main manifestations. APS-1 does, nonethele...
Report ID: 2357 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
DNA/RNA Sample Extraction and Isolation Market Size is valued at USD 2.47 Bn in 2023 and is predicted to reach USD 4.14 Bn by the year 2031 at a 6.80% CAGR during the forecast period for 2024-2031. The extraction and isolation of DNA/RNA samples are critical operations in molecular biology and genetics research. They involve the extraction of nucleic acids (DNA and RNA) from cells, tissues, or biological fluids for use in PCR, seque...
Report ID: 2199 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
HIV-Associated Lipodystrophy Treatment Market Size is valued at USD 176.82 Mn in 2023 and is predicted to reach USD 239.62 Mn by the year 2031 at a 4.05% CAGR during the forecast period for 2024-2031. HIV-associated lipodystrophy is an unfavourable side effect of antiretroviral therapy (ART). Lipodystrophy, often HIV-associated lipodystrophy, is a disease unique to HIV-positive people. Facial, gluteal, thigh, and limb subcutaneous f...
Report ID: 2250 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Pharmaceuticals